Bioinformatics sits at the convergence of computational methods, life sciences, diagnostics and data analytics. Advances in computational power and efficiencies and the increased capabilities of AI methods mean developments in genomics, diagnostics, computational biology and AI‐driven drug discovery are driving forward at pace. Patenting in this field shows ever increasing activity, indicative of the commercially valuable nature of innovation in this field. However, with these emerging and rapidly developing technologies come intellectual property complexity and challenges. This article considers key patenting trends and patent protection considerations in bioinformatics.

What is Bioinformatics?

Bioinformatics is the science of using computational tools and methods to analyse biological data, particularly large datasets such as genomic sequences or protein structures. In the context of pharmacy, bioinformatics plays a vital role in drug discovery, development and personalised medicine by helping researchers identify new drug targets, predict how drugs will interact with specific genes or proteins and tailor treatments based on individual genetic profiles. As pharmaceutical research becomes increasingly data-driven, bioinformatics serves as a key bridge between laboratory science and clinical application.